EOM Pharmaceuticals Holdings, Inc. (IMUC)

IMUC Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.55	1.49	0.26
Cash & Short-Term Investments	0.55	1.49	0.26
Cash Growth	109.59%	465.28%	-
Prepaid Expenses	0.16	0.18	-
Total Current Assets	0.71	1.67	0.26
Other Long-Term Assets	-	-	0
Total Assets	0.71	1.67	0.27
Accrued Expenses	0.73	0.47	0.14
Total Current Liabilities	0.73	0.47	0.14
Long-Term Debt	3.05	2.82	-
Total Liabilities	4.44	3.28	0.14
Common Stock	0.01	0.01	0
Additional Paid-In Capital	5.05	4.97	1.58
Retained Earnings	-8.78	-6.6	-1.45
Total Common Equity	-3.73	-1.62	0.13
Shareholders' Equity	-3.73	-1.62	0.13
Total Liabilities & Equity	0.71	1.67	0.27
Total Debt	3.05	2.82	-
Net Cash (Debt)	-2.5	-1.33	0.26
Net Cash Per Share	-0.03	-0.03	0.01
Filing Date Shares Outstanding	113.27	113.27	50
Total Common Shares Outstanding	113.27	113.27	50
Working Capital	-0.02	1.2	0.13
Book Value Per Share	-0.03	-0.01	0.00
Tangible Book Value	-3.73	-1.62	0.13
Tangible Book Value Per Share	-0.03	-0.01	0.00

Updated Dec 20, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.